Andrew Moin
Director/Board Member chez SAB BIOTHERAPEUTICS, INC.
Profil
Andrew Moin is currently the Director at SAB Biotherapeutics, Inc. and an Analyst at Sessa Capital IM LP.
He completed his undergraduate degree at Amherst College in 2005 and his graduate degree at Harvard Law School in 2008.
Postes actifs de Andrew Moin
| Sociétés | Poste | Début |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Director/Board Member | 05/10/2023 |
Sessa Capital IM LP
 Sessa Capital IM LP Investment ManagersFinance Sessa Capital IM LP (Sessa Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by John Petry in 2007. Sessa Capital provides investment advisory and management services on a discretionary basis to private pooled investment vehicles. | Analyst-Equity | 01/08/2012 |
Formation de Andrew Moin
| Amherst College | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sessa Capital IM LP
Sessa Capital IM LP Investment ManagersFinance Sessa Capital IM LP (Sessa Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by John Petry in 2007. Sessa Capital provides investment advisory and management services on a discretionary basis to private pooled investment vehicles. | Finance |
